Safe PN Compounding and Administration
October 2017 - Vol. 14 No. 10 - Page #6

Despite parenteral nutrition (PN) being designated a high-alert medication by The Institute for Safe Medication Practices (ISMP),1 a recent survey reported that only slightly more than half of organizations have precautions in place to prevent errors and patient harm associated with PN use.2 The American Society for Parenteral and Enteral Nutrition’s (ASPEN) Parenteral Nutrition Safety Consensus Recommendations address safety concerns throughout the PN process, including prescribing, order review and verification, compounding, and administration of PN.3 Compliance with these recommendations is critical to prevent PN errors and avert the potential for patient harm throughout the PN process; thus, organizations must ensure they fully understand and implement the ASPEN recommendations.

To read the full article, please log in or register.

WHERE TO FIND: Outsourced Compounding Services

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: